Real-world data for efficient health technology assessment

Affiliations

Editorial

Peter S Hall. Eur J Cancer. 2017 Jul.

. 2017 Jul:79:235-237.

doi: 10.1016/j.ejca.2017.04.003. Epub 2017 May 15.

¹ Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK. Electronic address: p.s.hall@ed.ac.uk.

No abstract available

Comment on

Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium.
van Kampen RJW, Ramaekers BLT, Lobbezoo DJA, de Boer M, Dercksen MW, van den Berkmortel F, Smilde TJ, van de Wouw AJ, Peters FPJ, van Riel JMG, Peters NAJB, Tjan-Heijnen VCG, Joore MA. van Kampen RJW, et al. Eur J Cancer. 2017 Jul;79:238-246. doi: 10.1016/j.ejca.2017.01.027. Epub 2017 Feb 27. Eur J Cancer. 2017. PMID: 28245951 Clinical Trial.